U.S. government to test Pfizer’s Paxlovid for long COVID

Peoria, IL, USA 102.7 Super Hits

By Julie Steenhuysen

CHICAGO (Reuters) – The U.S.-government-backed Recover study of long COVID will examine Pfizer Inc’s antiviral drug Paxlovid in a clinical trial of 1,700 patients, organizers said on Thursday.

(Reporting By Julie Steenhuysen in Chicago; Editing by Peter Henderson and Mark Porter)

Analysis-Under global spotlight, Australia plays hardball on social media ban

4h ago

BOJ to raise rates with eye on Iran war fallout, central bank official says

24m ago

Microsoft to invest $10 billion in Japan for AI and cyber defence expansion

46m ago

Inspection finds 49 violations of detention standards at largest US migrant detention camp

1h ago

Japan finance minister warns of high FX volatility, signals readiness to act

2h ago

China services activity growth cools in March, private PMI shows

2h ago

Peoria | WPBG-HD2 | 1027superhits.com

Now Playing

102.7 Super Hits

Loading Songs

No feed items available at this time.

Pause Auto-Update | Back to Top

U.S. government to test Pfizer’s Paxlovid for long COVID

Current Weather »

Peoria, IL

102.7 Super Hits on FB